TNDM - Tandem Corp Trailing Twelve Months Revenue Growth

Tandem Diabetes Care (TNDM) possesses significant pricing power due to patient reliance on its unique software. The 12-month revenue growth trajectory confirms this status, with 6.80 recorded as the baseline value. Growth is supported by the sale of consumables and expansion into global markets, while production stability is guaranteed by strategic component stockpiling and the diversification of electronics supplies.
tandemdiabetes.com (TNDM) - metric breakdowns and financial figures

This indicator identifies systemic degradation or business growth by measuring the average daily net revenue increase over a rolling year to eliminate seasonal distortions. By analyzing the TTM revenue change, an investor can discern the real demand for Tandem Diabetes Care (TNDM) compact insulin pumps and the effectiveness of their integration with glucose monitoring, confirming the company's expansion in the global market.